Daniela Stricklin

Daniela Stricklin, Ph.D., MPH, is a regulatory affairs professional with expertise on in vitro diagnostics (IVD) and medical device regulation spanning a wide range of applications such as precision medicine with companion diagnostics (CDx) and radiation assessment. She has a wealth of knowledge in the public health sector, toxicology, risk assessment, development of laboratory derived tests (LDTs), and radiation health sciences.

Dr. Stricklin has held prominent positions within the government and private sector, including as Branch Chief of the Pathology and Physiology Research Branch at the CDC’s National Institute for Occupational Safety and Health, as Team Lead and Senior Scientific Reviewer in the Division of Molecular Genetics and Pathology at the FDA's Center for Devices and Radiological Health, and as Program Manager at the U.S. Department of Energy. As a Principal Scientist at Applied Research Associates, she led innovative computational modeling efforts leveraging biomedical data to develop predictive models and software applications that provided support to therapeutic and diagnostic applications.

She holds a Ph.D. in Environmental Health Sciences from Johns Hopkins University, an MPH in Molecular Epidemiology from the University of Pittsburgh, and a B.S. in Chemistry. Dr. Stricklin has served on advisory boards for NIH and industry and received numerous honors, including awards from NATO, the DOE Secretary's Achievement Award, and recognition by NIH/NIAID.